Originally published In Press as doi:10.1074/jbc.M000585200 on April 3, 2000
J. Biol. Chem., Vol. 275, Issue 26, 20012-20019, June 30, 2000
Mechanism of Inactivation of Ornithine Transcarbamoylase by
N
-(N'-Sulfodiaminophosphinyl)-L-ornithine,
a True Transition State Analogue?
CRYSTAL STRUCTURE AND IMPLICATIONS FOR CATALYTIC MECHANISM*
David B.
Langley
,
Matthew D.
Templeton§,
Barry A.
Fields
,
Robin E.
Mitchell§, and
Charles A.
Collyer
¶
From the
Department of Biochemistry, The University
of Sydney, Sydney 2006, Australia and the § Horticultural
and Food Research Institute of New Zealand, Mt Albert Research Centre,
Auckland 1003, New Zealand
Received for publication, January 27, 2000, and in revised form, March 16, 2000
 |
ABSTRACT |
The crystal structure is reported at 1.8 Å resolution of Escherichia coli ornithine transcarbamoylase
in complex with the active derivative of phaseolotoxin from
Pseudomonas syringae pv. phaseolicola,
N
-(N'-sulfodiaminophosphinyl)-L-ornithine.
Electron density reveals that the complex is not a covalent adduct as
previously thought. Kinetic data confirm that
N
-(N'-sulfodiaminophosphinyl)-L-ornithine
exhibits reversible inhibition with a half-life in the order of ~22 h
and a dissociation constant of KD = 1.6 × 10
12 M at 37 °C and pH 8.0. Observed
hydrogen bonding about the chiral tetrahedral phosphorus of the
inhibitor is consistent only with the presence of the R enantiomer. A
strong interaction is also observed between Arg57 N
and
the P-N-S bridging nitrogen indicating that imino tautomers of
N
-(N'-sulfodiaminophosphinyl)-L-ornithine
are present in the bound state. An imino tautomer of
N
-(N'-sulfodiaminophosphinyl)-L-ornithine
is structurally analogous to the proposed reaction transition state.
Hence, we propose that N
-(N'-sulfodiaminophosphinyl)-L-ornithine,
with its three unique N-P bonds, represents a true transition state
analogue for ornithine transcarbamoylases, consistent with the tight
binding kinetics observed.
 |
INTRODUCTION |
Ornithine transcarbamoylase (OTCase, ornithine
carbamoyltransferase; E.C.
2.1.3.3)1 catalyzes the
reaction between carbamoyl phosphate (CP) and L-ornithine (Orn) to form L-citrulline and phosphate (Fig.
1a). In plants and microbes
OTCase is involved in arginine biosynthesis, whereas in mammals it is
located in the mitochondria and is part of the urea cycle. Although not
thermodynamically favored, the reverse reaction is efficiently
catalyzed by a specialized catabolic OTCase (1). This activity is found
in microbes that possess the arginine deiminase pathway, which enables
the generation of ATP under anaerobic conditions (2). OTCase is closely
related to some other carbamoyltransferases, most notably aspartate
transcarbamoylase (ATCase, aspartate carbamoyltransferase; E.C.
2.1.3.2) (3), the key allosteric pyrimidine biosynthetic enzyme. The
catalytic subunits of transcarbamoylases are composed of two domains: a
CP-binding domain and an amino acid-binding domain. Each of the two
discrete substrate-binding domains (SBDs) have an
/
topology with
a central
-pleated sheet embedded in flanking
-helices. The basic
quaternary structure is a trimer, with active sites located at the
interface between the protein monomers (4, 5). Anabolic OTCase is the
simplest form of the enzyme, comprising a single homotrimeric unit (1),
whereas the catabolic OTCase is a dodecamer of four trimers in a
tetrahedral arrangement (5). ATCase is also a dodecamer with two
trimers and three regulatory dimers (4). Amino acid sequences and
resultant structures of the CP-binding domains are very closely related within this transcarbamoylase family. Conservation of key
substrate-binding residues suggests that these transcarbamoylases share
a common chemical mechanism.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1.
Kekulé representation of proposed
OTCase mechanism and inhibitors. a, proposed reaction
mechanism for OTCase. The side chain amino group of Orn undergoes a
nucleophilic attack upon the carbonyl carbon of CP (left) to
form a tetrahedral transition state (middle). The Orn
zwitterion with an uncharged -amino group is shown. Charge
rearrangement releases citrulline and phosphate (right).
b, amino (left) and imino (middle)
tautomers of PSOrn compared with PALO (right).
|
|
OTCase has a compulsory ordered mechanism with CP the first substrate
to bind and phosphate the last product released (6-9). The enzyme from
Escherichia coli W follows a Theorell-Chance mechanism where
the concentration of the ternary complex is kinetically insignificant
(8). pH studies indicate that only the Orn zwitterion with an uncharged
-amino group binds productively to OTCase (9). The chemical
mechanism involves a nucleophilic attack from the electron pair of the
-amino group of Orn on the carbonyl group of CP. The transition
state (TS) is postulated to involve an oxyanion tetrahedral
intermediate (Fig. 1a) (10, 11). The roles of active site
residues in stabilizing an oxyanion intermediate are unknown, but two
conserved arginine residues contribute positive charges to the active
site. Whereas Arg106 is thought to interact with the
carbonyl oxygen of CP, Arg57 is also implicated in
catalysis. Mutation of Arg57 to Gly results in poor
catalytic efficiency with kcat reduced by
~104 (12).
Two OTCase crystal structures have been solved with the bisubstrate
analogue
N
-(phosphonoacetyl)-L-ornithine
(PALO) (13) (Fig. 1b) bound to the active site (11, 14) and
are related to the crystal structure of ATCase in complex with the
inhibitor N-(phosphonoacetyl)-L-aspartate (PALA)
(15, 16). Comparison of these structures with unliganded enzyme
structures (17, 18) demonstrate that OTCase and ATCase undergo a
conformational change upon substrate binding, bringing substrates
together and facilitating condensation (14, 19). Specifically, in
OTCases, the binding of substrates and/or inhibitors induces a
conformational change in the 240s
loop2 to form a closed conformation.
N
-(N'-Sulfodiaminophosphinyl)-L-ornithine
(PSOrn; Fig. 1b) is an extremely potent inhibitor of OTCases
from a variety of sources (20, 21). PSOrn is produced by aminopeptidase
cleavage of phaseolotoxin, the tripeptide phytotoxin produced by the
bean pathogen Pseudomonas syringae pv.
phaseolicola (22, 23). PSOrn has an unusual structure
involving three N-P bonds (24) but has structural similarities to PALO
and to the substrates of OTCase. OTCase is inactivated by PSOrn
stoichiometrically, and it was suggested that this interaction might be
via a covalent linkage (21). To characterize the nature of this
interaction, we have crystallized the OTCase-PSOrn complex and refined
the structure at high resolution. Implications for the chemical
mechanism of transcarbamoylases are discussed.
 |
EXPERIMENTAL PROCEDURES |
Expression and Purification of OTCase--
The argI
coding sequence from E. coli K12 was polymerase chain
reaction-amplified from the plasmid pAI102 (25) and cloned into the
expression vector pKK223-3 (Amersham Pharmacia Biotech). Expression
levels of up to 100 mg of OTCase/liter of culture were obtained. The
bisubstrate analogue for OTCase, PALO was synthesized as described by
de Martinas et al. (26) and linked to epoxy-activated Sepharose 6B (Amersham Pharmacia Biotech). OTCase was purified to
homogeneity in a one-step affinity procedure as described by Templeton
et al. (27), except that the extraction buffer was 50 mM TAPS, pH 8.0, 1 mM phenylmethylsulfonyl
fluoride, and 1 mM dithiothreitol. OTCase was assayed in 50 mM TAPS, pH 8.0, 5 mM CP and 3 mM
Orn, using colorimetric determination of citrulline (27). Purified
enzyme had a specific activity between 1250 and 1450 units/mg protein
under these conditions. The mass of the purified OTCase monomer was
determined as 36,775.2 (± 1.0) Da (calculated 36,775.65) using a LC-Q
electrospray mass spectrometer (Finnigan, San Jose, CA).
Purification of PSOrn--
Unlabeled PSOrn was prepared as
previously reported (23). [14C]PSOrn was purified from an
150-ml culture filtrate of P. syringae pv.
phaseolicola ICMP 4419 grown on minimal medium at 18 °C.
After 2.5 days of growth 20 µCi of
[U-14C]-L-Orn (Amersham Pharmacia Biotech)
was added, and the culture was harvested 12 h later.
14C-Labeled phaseolotoxin was purified by chromatography on
quaternary aminoethyl- and LH-20 Sephadex (Amersham Pharmacia Biotech).
Approximately 2% of the PSOrn was radiolabeled.
[14C]phaseolotoxin (0.75 mg) was reacted with 4 units of
leucine aminopeptidase (Sigma) in 200 µl of 25 mM
ammonium bicarbonate buffer, pH 7.8, for 16 h. Completion of the
reaction was confirmed by two-dimensional thin layer chromatography.
The reaction mixture was loaded onto a quaternary aminoethyl-Sephadex
column, and [14C]PSOrn was eluted with a 0.05-0.5
M ammonium bicarbonate gradient.
[14C]PSOrn Exchange Measurements--
OTCase (20 nmol) was inactivated with [14C]PSOrn (25 nmol) in 50 mM TAPS, pH 8.0. The inactivated OTCase was desalted on a
PD-10 column (Amersham Pharmacia Biotech), filter sterilized, and
incubated with a 200-fold excess of unlabeled PSOrn in 50 mM TAPS, pH 8.0, at 37 °C. Samples were removed at the
appropriate times and desalted on a PD-10 column to remove free
[14C]PSOrn, and the 14C in the void volume
was measured. 14C samples were counted for 10 min in an LKB
1214 Rackbeta liquid scintillation counter (Amersham Pharmacia Biotech).
Calculation of Observed Rate Constant for PSOrn
Binding--
Equimolar concentrations of OTCase and PSOrn (1 nM) were incubated in 1 ml of 50 mM TAPS, pH
8.0, at 37 °C. Portions (50 µl) were removed at 30-s intervals and
assayed for OTCase activity. Results were plotted as
1/e
1/e0 against time, where
eo is the initial concentration of enzyme and
e is the concentration of active enzyme at time
t. The slope of this line equals the observed second-order
rate constant (28, 29) for the binding of PSOrn to OTCase.
Crystallization of Inactivated OTCase--
Purified OTCase
(5-10 mg) was incubated with a 50% molar excess of PSOrn for 30 min
at 0 °C. Enzyme activity was inhibited by >99% under these
conditions. Inactivated enzyme was desalted on a PD-10 column
equilibrated in 20 mM HEPES, pH 7.5, containing 1 mM dithiothreitol and frozen. The screening of conditions
for crystal growth was conducted using the hanging drop vapor diffusion technique under normal oxidizing conditions at room temperature. Crystals most suitable for structure determination were obtained when
equal volumes of protein (8 mg/ml) were combined with an aqueous
solution containing polyethylene glycol 8000 17.8% (w/v) and
polyethylene glycol 1000 2.2% (w/v) at pH 5.5 (mother liquor). After
1-2 weeks pyramidal crystal forms were observed. Such large irregular
crystals were prepared for cryo conditions by equilibration (5-10 min)
in a solution containing 21% (w/v) polyethylene glycol (8000:1000 as
detailed for the mother liquor), with 20% (v/v) 2-methyl-2,4-pentanediol as cryoprotectant.
Cryoprotected crystals were flash frozen in a stream of nitrogen at
160 °C. The x-ray diffraction intensities were recorded with an
R-Axis II detector (MSC, The Woodlands, TX) to a resolution of 1.7 Å.
The data were reducible with Rmerge = 4.6%
(23.5%) and 86% (35%) completeness with I/
= 18.7 (2.9) (values in parentheses for the 1.76-1.70 Å shell) in a
primitive orthorhombic cell (a = 86.7, b = 134.2, c = 109.3 Å). Systematic
absences for (h 0 0) and (0 k 0) but not for
(0 0 l) reflections indicated that the space group was
probably P21212. This space group
was confirmed by translation function results detailed below. The
asymmetric unit of the observed cell contains one OTCase trimer, and
the volume is ~50% occupied by solvent.
Structure Solution and Refinement--
The primitive
orthorhombic data were probed by molecular replacement using the
program Amore (30) with trimeric search models derived (excluding PALO
and solvent) from the 2.8 Å resolution crystal structures of
PALO-liganded E. coli OTCase (14) and the apo enzyme (18)
(Protein Data Bank entries 2OTC and 1AKM, respectively). A significant
peak (more than twice the next largest peak) was observed in the
cross-rotation functions calculated from 8-4 Å resolution with both
search models using a 40 Å sphere radius. Translation searches were
conducted with data from 8 to 4 Å resolution in space groups
P222, P21212 and
P2122, and a unique solution was identified in
P21212. The PALO-liganded E. coli OTCase search model gave an optimal fit with a correlation
coefficient of 0.57 against backgrounds of maxima at 0.30. Rigid body
refinement of the search model with data to 2.3 Å increased the
correlation coefficient to 0.63 (r = 36% and
Rfree = 37%). A SigmaA (31) weighted
Fo
Fc map revealed a
pair of dominant peaks (>11
) at each of the three CP-binding
domains in the trimer matching the phosphorus and sulfur atoms of bound
PSOrn.
Refinement of atomic positions and B-factors was carried out
using Crystallography and NMR System, Version 0.5 (32). The structural
model output from Amore was subjected to 600 steps of torsion angle
molecular dynamics with a starting temperature of 2500 K. This resulted
in r = 28% and Rfree = 32%
using all data to 2.3 Å. From these coordinates one monomer was
selected and the noncrystallographic symmetry (NCS) operators required to generate the other two monomers were calculated. Strict NCS constraints were then applied. The phosphorus and sulfur atoms previously identified were included in the model with r = 31% and Rfree = 32% at 2.3 Å resolution.
Subsequent refinement and inclusion of data to 2.0 Å resulted in
r = 32% and Rfree = 33%. The
trimer was generated, and NCS restraints were applied. Energy minimization and B-refinement resulted in r = 28% and Rfree = 31% at 2.0 Å resolution. At
this stage water molecules were gradually incorporated into the model.
An electron density feature was modeled as a water molecule if it was
>4
(3.5
in the final stages) in Fo
Fc maps and made at least one hydrogen bonding
contact in the range 2.5-3.5 Å. Subsequent refinement using the data
to 1.8 Å resolution reduced R and
Rfree to 25 and 27%, respectively, and resulted
in Fo
Fc electron
density around the binding site as shown in Fig.
2. PSOrn was modeled into this density. A
search of the Cambridge Structural Data Base using various fragments of
the PSOrn structure resulted in one related compound,
bis(di-isopropylamino)-(phenyl(trifluoro-methylsulfonyl)amino)phosphine oxide. Values for P-N, P=O, N-S, and S=O bond-lengths, as well as
relevant bond angles, were obtained from this crystal structure (33)
and used as initial refinement restraints in Crystallography and NMR
System Version 0.5. During the final stages of refinement, these
restraints were removed, and the bond lengths and angles were
restrained to be identical in each of the three PSOrn molecules in the
trimer of OTCase. Further rounds of refinement including manual model
adjustments, removal of NCS restraints, and addition of more water
molecules resulted in r = 19.2% and
Rfree = 22.1% using all data to 1.7 Å. For the
last cycles the reflections used for Rfree were
included in the refinement resulting in r = 19.4%. The
final model contains three OTCase monomers, three PSOrn molecules, 735 water molecules, and one molecule of 2-methyl-2,4-pentanediol. The RMS
deviations from dictionary bond lengths and bond angles are 0.012 Å and 1.5°, respectively.

View larger version (70K):
[in this window]
[in a new window]
|
Fig. 2.
Contour of unbiased difference electron
densities observed at the PSOrn-binding site. Contour of unbiased
difference (Fo Fc)
electron densities (2.5 shown in blue cage) at 1.8 Å resolution observed at the PSOrn-binding site in subunit G after
phosphorus and sulfur atoms were added during the refinement (see
"Structure Solution and Refinement"). Similar densities were
observed in subunits H and I. The final refined positions of the atoms
of PSOrn are superposed and represented as CPK colored balls
and sticks.
|
|
 |
RESULTS |
Subunit Structure--
The OTCase-PSOrn monomer conformation
closely resembles that observed in the 2.8 Å crystal structure of the
E. coli OTCase-PALO complex (14). In both structures the
relative orientations of the SBDs are observed to be almost equivalent
with OTCase in the "closed" subunit conformation (Fig.
3). Superposing the individual SBDs of
the PALO complex with the SBDs of subunits G, H, and I of the PSOrn
structure leaves RMS differences of 0.4, 0.4, and 0.3 Å, respectively
for the 133 C
atoms comprising the CP-binding domain, and RMS
differences of 0.4, 0.4, and 0.4 Å for the 185 C
atoms comprising
the Orn-binding domain. These RMS differences are comparable with those
obtained when the entire subunits of the two tertiary structures are
superposed, with RMS differences of 0.4, 0.4, and 0.4 Å for 318 C
atomic positions, indicating the general equivalence of the
relative subunit conformations.

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 3.
C trace of a
superposition of OTCase inhibitor complexes. A C trace of a
superposition of the subunit structure of the E. coli
OTCase-PALO complex (1) (gray) with the H subunit of the
OTCase-PSOrn complex (shown in various colors). 318 structurally equivalent C atoms were superposed with an RMS
difference of 0.4 Å (34). The CP-binding domain is shown in
yellow, and the Orn-binding domain is in light
blue. The 80s loop is shown in dark blue, and the
corresponding 80s loop from subunit G, which forms the
interdomain-binding site is shown in red. Helix 9a (residues
283-291) is shown in pink. The side chains of
Met236 and Gln182, as well as PSOrn
(green) and PALO (yellow) are represented as
balls and sticks.
|
|
Oligomeric Structure--
Some small but significant differences
are observed in the quaternary arrangement of the three subunits of the
OTCase-PSOrn trimer when compared with the strictly NCS averaged
E. coli OTCase-PALO homotrimer (14). Although some deviation
from exact three fold symmetry is evident at high resolution in the
enzyme-PSOrn trimer, each of the three subunits are still closely
related, superposing with an RMS difference of 0.3 Å for 332 C
atoms. Two of the three subunits (H and I) can be superposed by a
rotation of 120.1°, whereas the third subunit (G) is orientated away
from the approximate 3-fold axis and is related to the other two
subunits by rotations of 120.4 and 119.5°, respectively.
A detailed comparison of the structures of the three independent
subunits G, H, and I reveals some small differences. As reported in
other transcarbamoylase structures, the 80-s loop from a neighboring subunit of the trimer (Fig. 3, shown in red), protrudes into
each of the three CP-binding sites to form an intersubunit active site (4). However, in the crystals analyzed here there are indications that
the sulfur atom of Met236, which interacts with the
neighboring subunits 80s loop (Fig. 3), is oxidized to either a
sulfoxide or sulfone. The varying levels of residual difference
electron densities within 2 Å of the sulfur atoms of
Met236 suggest that the extent of oxidation is not
equivalent in each of the three subunits, with G > I > H. The electron density for the 80s loop in the I subunit (interacting
with Met236 of the G subunit) is weak and is consistent
with the higher temperature factors (>50 Å2) as compared
with corresponding loops in subunits G and H. Only the side chain of
Lys86 within this loop of subunit I is modeled in a
conformation different to the well defined conformations observed in
subunits G and H. Nearby, helix 9a is located on the periphery of the
trimer and interacts with the 240s loop and a neighboring 80s loop
(Fig. 3, pink). Ordered conformations of helix 9a are
observed in subunits H and I and are directly involved in crystal
packing. However, in the G subunit helix 9a is partially disordered
with no observed electron density for parts of the main chain and most
of the side chains. Because of the crystal packing, there are no
possible partners for interactions with helix 9a of the G subunit. Side chains of helix 9a within subunits H and I interact via a number of
salt bridges (3 and 1, respectively) to other trimers in the crystal.
Other crystal packing effects may also be relevant to the small
deviation from exact 3-fold symmetry of the OTCase-PSOrn trimer. In the
asymmetric unit of the cell a single MPD molecule is observed to form
hydrogen bonds bridging two crystallographically related trimers. The
C-terminal amino acid carboxylate of subunit G (Lys333) is
linked via this bridge to the side chain of Lys151 of
subunit H.
The observed electron densities and refined temperature factors for
almost all of the amino acid side chains surrounding the three
crystallographically independent PSOrn molecules are consistent with
single conformations (other than the 80s loop of subunit I discussed
above). Pairwise superposition of 13 C
atoms adjacent (5 Å) to
bound PSOrn molecules allows a precise (RMS difference of 0.2 Å for
121 atoms) comparison of the substrate-binding sites in each of the
three subunits (not shown). In superposing the active sites, the
largest and most significant difference (>0.2 Å) is observed in the
CP-binding site of subunit G, whose guanidinium of Arg57,
in comparison with its position in the other subunits, is displaced laterally with respect to PSOrn by 0.4 Å. The carboxylate conformation of the nearby Glu87 (I subunit) is also altered to preserve
an intersubunit (I-G) salt bridge. Despite these small differences, the
same set of interactions with identically placed and structured PSOrn
molecules are observed in each of the three independent active sites
(Table I).
View this table:
[in this window]
[in a new window]
|
Table I
Intermolecular atomic distances observed for nonhydrogen atoms at the
PSOrn binding sites in subunits G, H, and L
The intramolecular distance between the oxygen (O1) of the sulfamyl
group and the nitrogen (N1) of PSOrn is also given. Gln82* is
the residue from another subunit of the trimer. Other close contacts
with hydrogen bond donors not orientated ideally to form a strong
hydrogen bond are also listed as possible interactions.
|
|
Structure of the PSOrn-binding Site--
PSOrn occupies the
adjacent Orn- and CP-binding sites found in the closed conformation of
each of the three subunits. Electron density clearly defines the
positions of all nonhydrogen atoms in each PSOrn molecule (Fig. 2), and
there is no evidence of covalent attachment to the enzyme as previously
postulated (21). Instead, PSOrn interacts noncovalently with
substrate-binding residues, consistent with kinetic experiments, which
show that PSOrn competes for the CP-binding site of OTCase (21). Around
the active site, the E. coli PSOrn-OTCase structure closely
parallels that reported at 1.85 Å resolution for PALO bound to human
OTCase (Fig. 4a) (11).
Gln82 of E. coli OTCase is not conserved in
OTCases, and the intersubunit interactions of its side chain are
substituted by similar interactions of the imidazole of
His117 in human OTCase. Additionally, the conformation of
the side chain amide of Gln136 is inverted when compared
with the conformation reported for Gln171 in the human
enzyme (11). The Gln136 side chain conformation is fixed by
hydrogen bonding with the proton-accepting carboxylate of
Asp140 (not shown). Other side chain positions in the PSOrn
bound complex, which are not equivalent to those in the PALO complex,
include Arg57 (see below), Met236, and
Cys273 (Fig. 4a).

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 4.
Stereo representations in ball and stick of
the conformation observed for PSOrn bound at the active site of
OTCase. a, superposition of the active sites of the
E. coli OTCase-PSOrn complex (subunit H) and the human
OTCase-PALO complex (11) (thick and thin ball and
stick, first and second amino acid numbers, respectively).
15 C atoms of ligand-binding residues were superposed with an RMS
difference of 0.2 Å (34). b, intermolecular hydrogen bonds
formed by PSOrn with OTCase are shown (black dashed lines).
Other possible interactions are also shown (green lines). In
both stereo images the identities of the oxygen and nitrogen atoms
bound to the chiral tetrahedral phosphorous atom (pink) are
derived from the hydrogen-bonding pattern shown in Fig. 5.
|
|
Not surprisingly, the Orn components of both PSOrn and PALO interact
with the Orn-binding domain in a similar fashion (Fig. 4a).
Briefly, the side chains of Asn167, Asp231, and
Ser235, and the peptide nitrogen of Met236
combine with two ordered water molecules to form a tight hydrogen bonding network surrounding the N3-amino (equivalent to the
-amino of Orn; see Fig. 5 for atom designation)
and carboxylate groups of PSOrn (Figs. 4b and 5). Local
hydrogen bonding networks suggest that the O
of Ser235
is indeed a hydrogen bond acceptor in its interaction with the PSOrn
N3-amino group. A tetrahedral arrangement of three hydrogen bond
acceptors around the N3-amino group is consistent with this amino group
being protonated, analogous to that proposed for the productive binding
of Orn (9). Adjacent to this site of recognition, the side chains of
Leu128, His133, Met236, and
Cys273 form a hydrophobic cleft in which the hydrocarbon
stem (C2, C3, and C4; Figs. 4b and 5) of PSOrn lies, and the
other face of which is solvent exposed.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 5.
Two-dimensional schematic diagram (35)
showing the hydrogen bonding interactions and other possible
interactions made by PSOrn at the active site of OTCase. Both the
hydrogen bonding interactions (black dashed lines) and other
possible interactions (green lines) are shown. Note that
each of the three crystallographically independent active sites display
the same set of interactions and can be represented by the one diagram.
The interatomic distances for each of the interactions displayed are
listed in Table I.
|
|
Amino acid conformations at the CP-binding site are also remarkably
similar despite distinct differences in the chemical structures of the
inhibitors. The sulfamyl group of PSOrn substitutes for the phosphonate
group in PALO (Figs. 1b and 4a). The carbonyl oxygen of PALO could be mimicked by either the phosphinyl oxygen (O3, Fig. 5) or amide (N) of PSOrn, depending on
the chirality of the PSOrn phosphorus. Although the electron density of
PSOrn alone does not allow discrimination between these possibilities, the former case is shown in Figs. 2 and 4 for reasons discussed below.
A significant difference noted when comparing the structures of bound
inhibitors concerns the relative position of the nitrogen in Fig. 5
(N1). In PSOrn, N1 is shifted toward one of the tetrahedally arranged sulfamyl oxygens (Figs. 4a and 5, O1).
However, despite this sulfamyl oxygen being only 3.1 Å from PSOrn
nitrogen N1, it is orientated and positioned poorly to form a strong
hydrogen bond (Fig. 4b, shown as a green line).
Similarly, despite N1 being 3.0 Å from the carbonyl oxygen of
Leu274, its orientation makes it unlikely to contribute to
a strong hydrogen bonding interaction. This is in contrast to the
equivalent nitrogen within the OTCase-PALO (11, 14) and ATCase-PALA
(16) complexes, which form hydrogen bonds with their corresponding leucines. Apart from this N1 nitrogen, the other two nitrogens within
the unique phosphotriamide of PSOrn (Fig. 5, N and
N2) do not have counterparts in PALO and PALA and
consequently form novel interactions with the CP-binding domain.
Chirality of PSOrn Phosphorus--
Electron density alone did not
allow discrimination to be made between lone oxygen and nitrogen atoms
bonded to the tetrahedral phosphorus of PSOrn (the lobes of electron
density appear similar, Fig. 2). Discrimination was achieved by
examination of the hydrogen bonding networks encompassing the inhibitor
(Figs. 4b and 5). One of these undefined atoms interacts (at
a distance of 2.6-2.8 Å) with the main chain carbonyl of
Cys273 and with the carbonyl of the side chain of
Gln136, which are both positioned as hydrogen bond
acceptors (Fig. 4b). The carbonyl of Leu274 and
the guanidinium of Arg319 are also in close contact (Fig.
4b, green lines). This arrangement of hydrogen
bond acceptor oxygens would interact strongly with a P-amino group but
is inconsistent with the presence of the alternative P=O oxygen
occupying this position within the PSOrn molecule.
The other undefined atom bound to the tetrahedral phosphorus forms
hydrogen bonds (2.7-3.1 Å) with three likely hydrogen bond donors;
these being the guanidinium group of Arg106, the imidazole
of His133, and the hydroxyl of Thr58 (Figs.
4b and 5). Although the guanidinium of Arg106 is
ideally orientated to donate a proton in a hydrogen bonding interaction
(at a distance of 2.7-2.8 Å), the roles of His133 and
Thr58 are readily deduced by examination of surrounding
hydrogen bonding networks. The pattern of hydrogen bonds imply that a
N
protonated tautomer of the imidazole of His133 is
present, enabling it to donate a proton to the undefined PSOrn atom,
and that a single rotamer of the side chain hydroxyl of Thr58 is predominant. This rotamer positions the proton of
the hydroxyl to donate in a bifurcated hydrogen bonding interaction
with both the undefined PSOrn atom and a sulfamyl oxygen (Fig. 5). A
similar situation involving the phosphonacetyl group of PALO is also
evident when the high resolution human OTCase-PALO structure is
examined (Ref. 11; Protein Data Bank entry 1OTH). Although the
guanidinium of Arg319 is also in close proximity to this
second undefined PSOrn atom (2.9-3.1 Å), a strong hydrogen bond (not
shown) with Thr58 places the side chain in an inappropriate
orientation for a strong hydrogen bonding interaction. In fact, the
charged guanidinium of Arg319 is approximately equidistant
from both undefined atom positions about the tetrahedral phosphorus.
Hence, the manner in which Arg319 contributes to the
binding of PSOrn is likely to be a weaker electrostatic interaction
(Figs. 4b and 5, green lines). Although conserved
in OTCases, Arg319 is not conserved in ATCases and hence is
not thought to participate directly in catalysis. However, it has been
suggested to be functionally equivalent to Arg296 of
E. coli ATCase (conserved in ATCases) and may similarly
polarize the active site (36). Combined observations lead to the
conclusion that the P=O oxygen is located at this second undefined
position and that any negative charge on this oxygen is likely to be
stabilized by the nearby positively charged groups.
Given the diametrically different environments at two atomic positions
around the phosphotriamide, it is concluded that the chiral phosphorus
of bound PSOrn is present in the R configuration displayed in Figs. 2
and 4. Because the electron densities indicate unit occupancy for the
inhibitor bound in the crystal, it is apparent that the R enantiomer is
the biologically active configuration of the toxin. Given that binding
of PSOrn to OTCase appears to be stoichiometric, it is likely that the
phaseolotoxin, from which PSOrn is prepared, is also synthesized
exclusively as the R enantiomer.
P-N-S Bridging Nitrogen of PSOrn--
The P-N-S bridging nitrogen
is unique in PSOrn. In PALO and PALA it is replaced by a
CH2, which attaches a phosphonate group to a carbonyl
oxygen (Fig. 1b). A particularly prominent difference in
active site amino acid conformation between the PSOrn, PALO, and PALA
complexes concerns the side chain of Arg57 (Fig.
4a). The N
of Arg57 is 2.8 Å from the
bridging nitrogen of PSOrn compared with the corresponding distances of
3.4 Å to the bridging CH2 carbons of PALO (Protein Data
Bank entries 2OTC and 1OTH) and PALA (subunit C of Protein Data Bank
entry 1D09). In the PALO and PALA crystal structures, the equivalent of
Arg57 stabilizes the binding of a phosphonate group. In the
PSOrn structure, a similar interaction is observed whereby the
guanidinium of Arg57 hydrogen bonds a sulfamyl oxygen.
These same sulfamyl/phosphonate oxygens form a second hydrogen bond
with the main chain amides of the same respective arginines (Figs.
4b and 5). Uniquely, in the PSOrn structure, the N
of
Arg57 makes a third hydrogen bond, acting as a donor to the
P-N-S bridging nitrogen of the inhibitor. The nature of this third
hydrogen bond can be gleaned with some certainty. Firstly, the N
of
this arginine is almost certainly protonated as the guanidinium side
chain of arginine is the most polar of all amino acid side chains (37). Secondly, the N
hydrogen position is defined accurately by known bond length (0.94 Å) and by the observed plane of the nonhydrogen atomic positions of the guanidinium group. The orientation of this
guanidinium group is such that the position of the N
hydrogen is
coplanar with the P-N-S bridge (with bridging nitrogen ~1.9 Å distant). In this context, the P-N-S nitrogen of PSOrn can only be a
hydrogen bond acceptor if bound PSOrn is present as an imino tautomer,
consistent with the inferred polarization of the
N
-(N'-sulfodiaminophosphinyl)
moiety (Fig. 1b). With the exception of these novel
interactions, all of the hydrogen bonding interactions that are
observed in the bound PSOrn complex are most similar to
those reported for the allied PALO complexes.
Determination of Rate Constants for Formation of the OTCase-PSOrn
Complex--
The observation that PSOrn is bound noncovalently to the
OTCase active site required re-evaluation of previous experiments, which indicated otherwise (21). The OTCase-PSOrn complex could not be
dissociated by ethanol precipitation, extensive dialysis, or gel
filtration in the presence of 10 mM CP (Ref. 21 and data not shown). However, when [14C]PSOrn-OTCase was
challenged with a 200-fold excess of 12C-PSOrn, a linear
rate of competition was observed, where the OTCase-PSOrn half-life is
~22 h (Fig. 6a). Binding is
clearly reversible. Although an observed off constant
(koff) for the dissociation of the complex was
calculated to be 9 × 10
6
s
1 (Fig. 6a), an observed on constant
(kon) for the formation of complex was
calculated to be 5.8 × 106
M
1 s
1 (Fig. 6b).
Thus a dissociation constant (where KD=
koff/kon) was determined
to be ~1.6 × 10
12 M. This is
106-fold lower than the dissociation constant for CP
(3-15 × 10
6 M) (8, 21) and
~106-fold lower than the dissociation constant for the
bisubstrate inhibitor PALO (0.8 × 10
6
M) (38). The extremely low dissociation constant estimated for the OTCase-PSOrn complex warrants PSOrn to be included as a member
of the tight binding class of enzyme inhibitors (39).

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 6.
Calculation of the observed off and on rate
constants for PSOrn. a, estimation of
koff. [14C]PSOrn-OTCase was
incubated with a 200-fold excess of unlabeled PSOrn in 50 mM TAPS pH 8.0 at 37 °C. Samples were removed at 0, 2, 4, 6, 8, 10, 12, and 24 h, and the 14C remaining bound
was measured ( ) as compared with a control experiment with no
unlabeled PSOrn ( ). Each time point was measured in triplicate, and
the slope was calculated by linear regression (r = 0.99645, p < 0.0001). b, estimation of
kon. Equimolar concentrations of OTCase and
PSOrn (1 nM) were incubated in 1 ml of 50 mM
TAPS, pH 8.0, at 37 °C. Results were plotted as 1/e 1/e0 against time, where
eo is the initial concentration of enzyme and
e is the concentration of active enzyme at time
t. The experiment was performed in triplicate, and the slope
was calculated by linear regression (r = 0.96866, p < 0.0001).
|
|
 |
DISCUSSION |
The OTCase reaction mechanism is thought to proceed through a
tetrahedral TS. This mechanism (Fig. 1a) is based on
structural data and isotopic experiments with OTCase and by analogy to
that proposed for ATCase (7, 9, 10, 11, 19, 40, 41). We propose that
PSOrn acts as a TS analogue (42) because it binds tightly yet
reversibly to OTCase and has close structural homology with the
proposed OTCase reaction mechanism TS.
As observed in OTCase-PALO complexes (11, 14), the binding of PSOrn
induces a compression of SBDs with the enzyme closing around the
inhibitor. Like PALO, PSOrn interacts with residues of the CP domain
that are generally conserved in the transcarbamoylase family comprising
OTCase and ATCase. Additional enzyme-inhibitor interactions observed in
the OTCase-PSOrn complex are relevant to our understanding of the
detail of the chemical mechanism. Particularly important are
interactions about the chiral phosphorus of PSOrn. A TS in which a
chiral tetrahedral carbon is obligatory would be analogous to the
binding of a particular enantiomer of PSOrn with respect to its chiral
phosphorus. A high energy state or any intermediate on the reaction
pathway that approximates an R configuration could of course be
stabilized by the very same set of hydrogen bonding interactions made
by PSOrn with OTCase. An R configuration in the TS would result from a
stereospecific nucleophilic attack. In this scenario, prepositioning
may be accompanied by enzyme-mediated distortion of the planar carbonyl
group of CP toward the final tetrahedral R configuration, sterically
assisting nucleophilic attack by the lone electron pair from the
-nitrogen of Orn. Alternatively, this could be considered to be a
preorganization of CP binding by the enzyme in the enzyme-substrate
complex. Although a chiral tetrahedral carbon in the TS is not a steric
requirement of the overall reaction, it is not uncommon that a
catalytic reaction pathway may include chiral structures.
Neither the predominant tautomer of PSOrn in solution (24) nor the
pKa value(s) of the chemical groups of PSOrn bound
to the active site of OTCase are known. The orientation and hydrogen
bonding interactions of the Orn component of PSOrn are consistent with
the presence of a zwitterion with a protonated
-amino group (N3,
Fig. 5). The protonation and charged state of the PSOrn groups
occupying the CP-binding site are less certain. With three positively
charged guanidinium groups nearby, it is possible that deprotonated
forms of PSOrn are the predominant bound species in these crystals. The
observation of a strong interaction involving the N
of
Arg57 indicates that the guanidinium group donates a
hydrogen to the lone pair of electrons of an sp2 hybridized imino
nitrogen (Figs. 4b and 5, N2). We conclude that
were the P-N-S nitrogen protonated, steric hindrance would shift the
guanidinium group of Arg57 back toward a position in space
similar to that observed in the PALO and PALA complexes. Additional
negative charge resulting from deprotonation of the bridging P-N-S
nitrogen could be stabilized by nearby guanidinium groups and by
delocalization between the sulfamyl and/or P=O oxygens. Of significance
to the catalytic mechanism, should Arg57 adopt a similar
conformation about CP, it would be acting to polarize the bridging
C-O-P oxygen on the pathway toward phosphate release (Fig.
1a).
Although the Orn and sulfamyl groups of PSOrn bind in orientations and
positions that approximate those observed for their counterparts in
complexes of PALO (Orn and phosphonate, respectively), the position of
the N1 nitrogen of the Orn component differs in the two complexes
(Figs. 4a and 5). N1 could interact with the main chain
carbonyl of Leu274 and/or a sulfamyl oxygen (Fig. 5). If
mirrored in the TS this proximity of N1 to the sulfamyl oxygen would be
consistent with concerted intramolecular proton transfer between the
Orn
-amino group and a terminal phosphate oxygen of CP (40), as
shown in Fig. 1a.
The strength of the OTCase-PSOrn interaction predicted from the
structural data is consistent with the low dissociation constant estimated (1.6 × 10
12 M). It is worth
noting that the kon observed for PSOrn (5.8 × 106 M
1 s
1) is
similar to the equivalent rate constant for CP (6.5 × 106 M
1 s
1) (8).
Hence, although PSOrn competes equally with CP for free enzyme, the
slow rate of dissociation (9 × 10
6
s
1) means that PSOrn effectively irreversibly inhibits
OTCase. Classical TS theory, which proposes that the enzymatic rate
enhancement (typically 1010-1018) (43) is
principally due to stabilization of an otherwise unlikely intermediate,
would predict that these TS-like inhibitors resemble the activated
substrate(s) in the TS as closely as is chemically feasible. Although
the OTCase catalytic rate of enhancement is unknown, the high affinity
of PSOrn relative to substrate (~106) implies that there
exists a substrate-like bound state for which the Gibbs free energy is
very much lower than the enzyme-substrate complex. This further
supports the hypothesis that a structural state analogous to the
OTCase-PSOrn complex forms part of the enzymatic reaction pathway.
Subtle differences in structure between the enzyme-inhibitor complex
and the TS may account for TS binding affinities that are even higher
than that reported here for PSOrn.
This study of the mode of action of PSOrn has conclusively identified
it as a tight-binding TS-like inhibitor of OTCase. The low dissociation
constant for PSOrn accounts for the potency of phaseolotoxin as a
phytotoxin and inhibitor of microbial growth (44). Given that the
unique features of the OTCase-PSOrn interaction are confined to the
conserved CP domain, it is likely that these observations are relevant
to the transcarbamoylase family in general. In particular, the
CP-binding sites of ATCases are almost structurally identical to those
of OTCases. Poor OTCase inhibition by phosphinylphosphinate bisubstrate
mimics, which contain a nonchiral tetrahedral phosphate (45), confirms
the importance of the TS-like configuration of PSOrn. This suggests
that inhibitors with the appropriate enantiomer of an
sulfodiaminophosphinyl group attached to the appropriate amino group of
the relevant amino acid could be potent inhibitors of other
transcarbamoylase enzymes.
 |
ACKNOWLEDGEMENTS |
We thank Dr. M. Wales at Texas A & M for
providing pAI102, Dr. J. Mackay in the Biochemistry Department at
Sydney University for performing the mass spectrometry, and Prof.
W. W. Cleland for critically reading the manuscript.
 |
FOOTNOTES |
*
This work was supported in part by the Marsden Fund,
administered by the Royal Society of New Zealand, contract HRT 801 (to M. D. T. and R. E. M).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1DUV) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
¶
To whom correspondence should be addressed: Dept. of
Biochemistry G08, University of Sydney, NSW 2006, Australia. Tel.:
61-2-93512794; Fax: 61-2-93514726; E-mail:
C.Collyer@biochem.usyd.edu.au.
Published, JBC Papers in Press, April 3, 2000, DOI 10.1074/jbc.M000585200
2
Nomenclature used to describe secondary
structure and loop regions is as previously defined (14).
 |
ABBREVIATIONS |
The abbreviations used are:
OTCase, ornithine
transcarbamoylase;
ATCase, aspartate transcarbamoylase;
CP, carbamoyl
phosphate;
NCS, noncrystallographic symmetry;
Orn, L-ornithine;
PALA, N-(phosphonacetyl)-L-aspartate;
PALO, N
-(phosphonacetyl)-L-ornithine;
PSOrn, N
-(N'-sulfodiaminophosphinyl)-L-ornithine;
RMS, root mean squared;
SBD, substrate-binding domain;
TAPS, N-tris[hydroxymethyl]methyl-3-aminopropanesulfonic acid;
TS, transition state.
 |
REFERENCES |
| 1.
|
Legrain, C.,
Stallon, V.,
Noullez, J. P.,
Mercenier, A.,
Simon, J. P.,
Broman, K.,
and Wiame, J. M.
(1977)
Eur. J. Biochem.
80,
401-409
|
| 2.
|
Stalon, V.,
and Mercenier, A.
(1984)
J. Gen. Microbiol
130,
69-76
|
| 3.
|
Houghton, J. E.,
Bencini, D. A.,
O'Donovan, G.,
and Wild, J. R.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
4864-4868
|
| 4.
|
Honzatko, R. B.,
Crawford, J. L.,
Monaco, H. L.,
Ladner, J. E.,
Ewards, F. P.,
Evans, D. R.,
Warren, S. G.,
Wiley, D. C.,
Ladner, R. C.,
and Lipscomb, W. N.
(1982)
J. Mol. Biol.
160,
219-263
|
| 5.
|
Villeret, V.,
Tricot, C.,
Stalon, V.,
and Dideberg, O.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10762-10766
|
| 6.
|
Miller, A. W.,
and Kuo, L. C.
(1990)
J. Mol. Biol.
265,
15023-15027
|
| 7.
|
Parmentier, L. E.,
and Kristensen, J. S.
(1998)
Biochim. Biophys. Acta Protein Struct. Mol. Enzymol.
1382,
333-338
|
| 8.
|
Legrain, C.,
and Stalon, V.
(1976)
Eur. J. Biochem.
63,
289-301
|
| 9.
|
Kuo, L. C.,
Herzberg, W.,
and Lipscomb, W. N.
(1985)
Biochemistry
24,
4754-4761
|
| 10.
|
Parmentier, L. E.,
Weiss, P. M.,
O'Leary, M. H.,
Schachman, H. K.,
and Cleland, W. W.
(1992)
Biochemistry
31,
6577-6584
|
| 11.
|
Shi, D.,
Morizono, H.,
Ha, Y.,
Aoyagi, M.,
Tuchman, M.,
and Allewell, N. M.
(1998)
J. Biol. Chem.
273,
34247-54
|
| 12.
|
Goldsmith, J. O.,
Lee, S.,
Zambidis, I.,
and Kuo, L. C.
(1991)
J. Biol. Chem.
266,
18626-34
|
| 13.
|
Hoogenraad, N. J.
(1978)
Archs. Biochem. Biophys.
188,
137-144
|
| 14.
|
Ha, Y.,
McCann, M. T.,
Tuchman, M.,
and Allewell, N. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
9550-9555
|
| 15.
|
Collins, K. D.,
and Stark, G. R.
(1971)
J. Biol. Chem.
246,
6599-6605
|
| 16.
|
Krause, K. L.,
Volz, K. W.,
and Lipscomb, W. N.
(1987)
J. Mol. Biol.
193,
527-553
|
| 17.
|
Ke, H. M.,
Honzatko, R. B.,
and Lipscomb, W. N.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
4037-4040
|
| 18.
|
Jin, L.,
Seaton, B. A.,
and Head, J. F.
(1997)
Nat. Struct. Biol.
4,
622-625
|
| 19.
|
Ke, H.,
Lipscomb, W. N.,
Cho, Y.,
and Honzatko, R. B.
(1988)
J. Mol. Biol.
204,
725-747
|
| 20.
|
Ferguson, A. R.,
and Johnston, J. S.
(1980)
Physiol. Plant Pathol.
16,
269-275
|
| 21.
|
Templeton, M. D.,
Mitchell, R. E.,
Sullivan, P. A.,
and Shepherd, M. G.
(1985)
Biochem. J.
228,
347-52
|
| 22.
|
Mitchell, R. E.,
and Bieleski, R. L.
(1977)
Plant Physiol.
60,
723-729
|
| 23.
|
Mitchell, R. E.
(1976)
Nature
260,
75-76
|
| 24.
|
Moore, R. E.,
Niemczura, W. P.,
Kwok, O. C. H.,
and Patil, S. S.
(1984)
Tetrahedron Lett.
25,
3931-3934
|
| 25.
|
Bencini, D. A.,
Houghton, J. E.,
Hoover, T. A.,
Foltermann, K. F.,
Wild, J. R.,
and O'Donovan, G. A.
(1983)
Nucleic Acids Res.
11,
8509-8518
|
| 26.
|
de Martinis, M. L.,
McIntyre, P.,
and Hoogenraad, N.
(1981)
Biochem. Int.
3,
371-378
|
| 27.
|
Templeton, M. D.,
Sullivan, P. A.,
and Shepherd, M. G.
(1984)
Biochem. J.
224,
379-388
|
| 28.
|
Arisawa, M.,
and Then, R.
(1983)
Biochem. J.
209,
609-615
|
| 29.
|
Knott-Hunziker, V.,
Orlek, B. S.,
Sammes, P. G.,
and Waley, S. G.
(1980)
Biochem. J.
187,
797-802
|
| 30.
|
Navaza, J.
(1994)
Acta Crystallogr. Sect. A
50,
157-163
|
| 31.
|
Read, R. J.
(1986)
Acta Crystallogr. Sect. A
42,
140-149
|
| 32.
|
Brunger, A. T.,
Adams, P. D.,
Clore, G. M.,
DeLano, W. L.,
Gros, P.,
Grosse-Kunstleve, R. W.,
Jiang, J. S.,
Kuszewski, J.,
Nilges, M.,
Pannu, N. S.,
Read, R. J.,
Rice, L. M.,
Simonson, T.,
and Warren, G. L.
(1998)
Acta Crystallogr. Sect. D Biol. Crystallogr.
54,
905-921
|
| 33.
| Burford, N., Spence, R. E. v. H., and Richardson, J. F. (1991) J. Chem. Soc. Dalton Trans. 1615-1619
|
| 34.
|
Guex, N.,
and Peitsch, M. C.
(1997)
Electrophoresis
18,
2714-2723
|
| 35.
|
Wallace, A. C.,
Laskowski, R. A.,
and Thornton, J. M.
(1995)
Protein. Eng.
8,
127-134
|
| 36.
|
Murata, L. B.,
and Schachman, H. K.
(1996)
Protein Sci.
5,
709-718
|
| 37.
|
Wolfenden, R.
(1983)
Science
222,
1087-1093
|
| 38.
|
Penninckx, M.,
and Gigot, D.
(1978)
FEBS Lett.
88,
94-96
|
| 39.
|
Williams, J. W.,
and Morrison, J. F.
(1979)
Methods Enzymol.
63,
437-467
|
| 40.
|
Gouaux, J. E.,
Krause, K. L.,
and Lipscomb, W. N.
(1987)
Biochem. Biophys. Res. Commun.
142,
893-897
|
| 41.
|
Waldrop, G. L.,
Urbauer, J. L.,
and Cleland, W. W.
(1992)
J. Am Chem. Soc.
114,
5941-5945
|
| 42.
|
Radzicka, A.,
and Wolfenden, R.
(1995)
Methods Enzymol.
249,
284-312
|
| 43.
|
Schramm, V. L.
(1999)
Methods Enzymol.
308,
301-354
|
| 44.
|
Staskawicz, B. J.,
and Panopoulos, N. J.
(1980)
J. Bacteriol.
142,
474-479
|
| 45.
|
Flohr, A.,
Aemissegger, A.,
and Hilvert, D.
(1999)
J. Med. Chem.
42,
2633-2640
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Aguilera, K. Lopez-Lopez, Y. Nieto, R. Garciduenas-Pina, G. Hernandez-Guzman, J. L. Hernandez-Flores, J. Murillo, and A. Alvarez-Morales
Functional Characterization of the Gene Cluster from Pseudomonas syringae pv. phaseolicola NPS3121 Involved in Synthesis of Phaseolotoxin
J. Bacteriol.,
April 1, 2007;
189(7):
2834 - 2843.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Lopez-Lopez, J. L. Hernandez-Flores, M. Cruz-Aguilar, and A. Alvarez-Morales
In Pseudomonas syringae pv. phaseolicola, Expression of the argK Gene, Encoding the Phaseolotoxin-Resistant Ornithine Carbamoyltransferase, Is Regulated Indirectly by Temperature and Directly by a Precursor Resembling Carbamoylphosphate
J. Bacteriol.,
January 1, 2004;
186(1):
146 - 153.
[Abstract]
[Full Text]
[PDF]
|
 |
|